Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Ratios

Rallybio (RLYB) Shares Issued (2024 - 2026)

Rallybio's Shares Issued history spans 2 years, with the latest figure at -$10000.0 for Q3 2025.

On a quarterly basis, Shares Issued rose 99.81% to -$10000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was -$10000.0, a N/A change, with the full-year FY2024 number at $5.4 million, changed N/A from a year prior.
Shares Issued hit -$10000.0 in Q3 2025 for Rallybio, down from $5.4 million in the prior quarter.
Over the last five years, Shares Issued for RLYB hit a ceiling of $5.4 million in Q4 2024 and a floor of -$5.4 million in Q3 2024.